Applications in image-based profiling of perturbations

Current Opinion in Biotechnology

Volumn 39, Issue , 2016, Pages 134-142

  Caicedo, Juan C ^a,b   Singh, Shantanu ^a   Carpenter, Anne E ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b FUNDACIÓN UNIVERSITARIA KONRAD LORENZ   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; DRUG PRODUCTS;

AUTOMATED IMAGE ANALYSIS; BIOLOGICAL PROPERTIES; BIOLOGICAL RESEARCH; FUNCTIONAL GENOMICS; HIGH THROUGHPUT; MICROSCOPY IMAGES; SMALL MOLECULES; TARGET IDENTIFICATION;

GENES;

DRUG; PROTEOME;

ALLELE; DRUG DEVELOPMENT; DRUG MECHANISM; FUNCTIONAL GENOMICS; GENE ACTIVITY; HUMAN; MICROSCOPY; MORPHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; SCREENING; SYSTEMS BIOLOGY; TOXICITY; ANIMAL; CELL FUNCTION; COMPUTER ASSISTED DIAGNOSIS; GENE EXPRESSION PROFILING; GENOMICS; MOLECULAR IMAGING; PROCEDURES;

ANIMALS; CELL PHYSIOLOGICAL PHENOMENA; DRUG DISCOVERY; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MICROSCOPY; MOLECULAR IMAGING; PHENOTYPE; PROTEOME;

EID: 84962815651     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2016.04.003     Document Type: Review

References (104)

1. Perlman Z.E., Slack M.D., Feng Y., Mitchison T.J., Wu L.F., Altschuler S.J. Multidimensional drug profiling by automated microscopy. Science 2004, 306:1194-1198.
2. Abraham Y., Zhang X., Parker C.N. Multiparametric analysis of screening data: growing beyond the single dimension to infinity and beyond. J Biomol Screen 2014, 19:628-639.
3. Johannessen C.M., Clemons P.A., Wagner B.K. Integrating phenotypic small-molecule profiling and human genetics: the next phase in drug discovery. Trends Genet 2015, 31:16-23.
4. Feng Y., Mitchison T.J., Bender A., Young D.W., Tallarico J.A. Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds. Nat Rev Drug Discov 2009, 8:567-578.
5. Peck D., Crawford E.D., Ross K.N., Stegmaier K., Golub T.R., Lamb J. A method for high-throughput gene expression signature analysis. Genome Biol 2006, 7:R61.
6. Weinstein J.N., Myers T.G., O'Connor P.M., Friend S.H., Fornace A.J., Kohn K.W., et al. An information-intensive approach to the molecular pharmacology of cancer. Science 1997, 275:343-349.
7. Barretina J., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012, 483:603-607.
8. Roguev A., Talbot D., Negri G.L., Shales M., Cagney G., Bandyopadhyay S., et al. Quantitative genetic-interaction mapping in mammalian cells. Nat Methods 2013, 10:432-437.
9. Cowley G.S., Weir B.A., Vazquez F., Tamayo P., Scott J.A., Rusin S., et al. Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies. Sci Data 2014, 1:140035.
10. Ghaznavi F., Evans A., Madabhushi A., Feldman M. Digital imaging in pathology: whole-slide imaging and beyond. Annu Rev Pathol 2013, 8:331-359.
11. Snijder B., Pelkmans L. Origins of regulated cell-to-cell variability. Nat Rev Mol Cell Biol 2011, 12:119-125.
12. Altschuler S.J., Wu L.F. Cellular heterogeneity: do differences make a difference?. Cell 2010, 141:559-563.
13. Snijder B., Sacher R., Rämö P., Liberali P., Mench K., Wolfrum N., et al. Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol 2012, 8:579.
14. Yin Z., Sadok A., Sailem H., McCarthy A., Xia X., Li F., et al. A screen for morphological complexity identifies regulators of switch-like transitions between discrete cell shapes. Nat Cell Biol 2013, 15:860-871.
15. Unadkat H.V., Hulsman M., Cornelissen K., Papenburg B.J., Truckenmüller R.K., Carpenter A.E., et al. An algorithm-based topographical biomaterials library to instruct cell fate. Proc Natl Acad Sci U S A 2011, 108:16565-16570.
16. Dalby M.J., Gadegaard N., Tare R., Andar A., Riehle M.O., Herzyk P., et al. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater 2007, 6:997-1003.
17. LaBarge M.A., Nelson C.M., Villadsen R., Fridriksdottir A., Ruth J.R., Stampfer M.R., et al. Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments. Integr Biol 2009, 1:70-79.
18. Uhlén M., Fagerberg L., Hallström B.M., Lindskog C., Oksvold P., Mardinoglu A., et al. Proteomics. Tissue-based map of the human proteome. Science 2015, 347:1260419.
19. Buck T.E., Li J., Rohde G.K., Murphy R.F. Toward the virtual cell: automated approaches to building models of subcellular organization learned from microscopy images. BioEssays 2012, 34:791-799.
20. Handfield L.-F., Chong Y.T., Simmons J., Andrews B.J., Moses A.M. Unsupervised clustering of subcellular protein expression patterns in high-throughput microscopy images reveals protein complexes and functional relationships between proteins. PLoS Comput Biol 2013, 9:e1003085.
21. Chong Y.T., Koh J.L.Y., Friesen H., Duffy S.K., Duffy K., Cox M.J., et al. Yeast proteome dynamics from single cell imaging and automated analysis. Cell 2015, 161:1413-1424.
22. Koh J.L.Y., Chong Y.T., Friesen H., Moses A., Boone C., Andrews B.J., et al. CYCLoPs: a comprehensive database constructed from automated analysis of protein abundance and subcellular localization patterns in Saccharomyces cerevisiae. G3 2015, 5:1223-1232.
23. Kasthuri N., Hayworth K.J., Berger D.R., Schalek R.L., Conchello J.A., Knowles-Barley S., et al. Saturated reconstruction of a volume of neocortex. Cell 2015, 162:648-661.
24. Oh S.W., Harris J.A., Ng L., Winslow B., Cain N., Mihalas S., et al. A mesoscale connectome of the mouse brain. Nature 2014, 508:207-214.
25. Ahrens M.B., Orger M.B., Robson D.N., Li J.M., Keller P.J. Whole-brain functional imaging at cellular resolution using light-sheet microscopy. Nat Methods 2013, 10:413-420.
26. Swierczek N.A., Giles A.C., Rankin C.H., Kerr R.A. High-throughput behavioral analysis in C. elegans. Nat Methods 2011, 8:592-598.
27. Chiang A.-S., Lin C.-Y., Chuang C.-C., Chang H.-M., Hsieh C.-H., Yeh C.-W., et al. Three-dimensional reconstruction of brain-wide wiring networks in Drosophila at single-cell resolution. Curr Biol 2011, 21:1-11.
28. Costanzo M., Baryshnikova A., Bellay J., Kim Y., Spear E.D., Sevier C.S., et al. The genetic landscape of a cell. Science 2010, 327:425-431.
29. Boutros M., Heigwer F., Laufer C. Microscopy-based high-content screening. Cell 2015, 163:1314-1325.
30. Singh S., Carpenter A.E., Genovesio A. Increasing the content of high-content screening: an overview. J Biomol Screen 2014, 19:640-650.
31. Swinney D.C., Anthony J. How were new medicines discovered?. Nat Rev Drug Discov 2011, 10:507-519.
32. Eggert U.S. The why and how of phenotypic small-molecule screens. Nat Chem Biol 2013, 9:206-209.
33. Eliceiri K.W., Berthold M.R., Goldberg I.G., Ibáñez L., Manjunath B.S., Martone M.E., et al. Biological imaging software tools. Nat Methods 2012, 9:697-710.
34. Sommer C., Gerlich D.W. Machine learning in cell biology - teaching computers to recognize phenotypes. J Cell Sci 2013, 126:1-11.
35. Jones T.R., Carpenter A.E., Lamprecht M.R., Moffat J., Silver S.J., Grenier J.K., et al. Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning. Proc Natl Acad Sci U S A 2009, 106:1826-1831.
36. Megason S.G., Fraser S.E. Imaging in systems biology. Cell 2007, 130:784-795.
37. Carpenter A.E. Image-based chemical screening. Nat Chem Biol 2007, 3:461-465.
38. Eggert U.S., Mitchison T.J. Small molecule screening by imaging. Curr Opin Chem Biol 2006, 10:232-237.
39. Bickle M. The beautiful cell: high-content screening in drug discovery. Anal Bioanal Chem 2010, 398:219-226.
40. Antony P.M.A., Trefois C., Stojanovic A., Baumuratov A.S., Kozak K. Light microscopy applications in systems biology: opportunities and challenges. Cell Commun Signal 2013, 11:24.
41. Taylor J., Woodcock S. A perspective on the future of high-throughput RNAi screening: will CRISPR cut out the competition or can RNAi help guide the way?. J Biomol Screen 2015, 20:1040-1051.
42. Shalem O., Sanjana N.E., Zhang F. High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet 2015, 16:299-311.
43. Mohr S.E., Smith J.A., Shamu C.E., Neumüller R.A., Perrimon N. RNAi screening comes of age: improved techniques and complementary approaches. Nat Rev Mol Cell Biol 2014, 15:591-600.
44. Ljosa V., Caie P.D., Ter Horst R., Sokolnicki K.L., Jenkins E.L., Daya S., et al. Comparison of methods for image-based profiling of cellular morphological responses to small-molecule treatment. J Biomol Screen 2013, 18:1321-1329.
45. Reisen F., Zhang X., Gabriel D., Selzer P. Benchmarking of multivariate similarity measures for high-content screening fingerprints in phenotypic drug discovery. J Biomol Screen 2013, 18:1284-1297.
46. Kümmel A., Selzer P., Beibel M., Gubler H., Parker C.N., Gabriel D. Comparison of multivariate data analysis strategies for high-content screening. J Biomol Screen 2011, 16:338-347.
47. Leek J.T., Scharpf R.B., Bravo H.C., Simcha D., Langmead B., Johnson W.E., et al. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet 2010, 11:733-739.
48. Ng A.Y.J., Rajapakse J.C., Welsch R.E., Matsudaira P.T., Horodincu V., Evans J.G. A cell profiling framework for modeling drug responses from HCS imaging. J Biomol Screen 2010, 15:858-868.
49. Loo L.-H., Lin H.-J., Steininger R.J., Wang Y., Wu L.F., Altschuler S.J. An approach for extensibly profiling the molecular states of cellular subpopulations. Nat Methods 2009, 6:759-765.
50. Volz H.C., Heigwer F., Wuest T., Galach M., Utikal J., Katus H.A., et al. Single-cell phenotyping of human induced pluripotent stem cells by high-throughput imaging. bioRxiv 2015, 5:026955. 10.1101/026955.
51. Fuchs F., Pau G., Kranz D., Sklyar O., Budjan C., Steinbrink S., et al. Clustering phenotype populations by genome-wide RNAi and multiparametric imaging. Mol Syst Biol 2010, 6:370.
52. LeCun Y., Bengio Y., Hinton G. Deep learning. Nature 2015, 521:436-444.
53. Kandaswamy C., Silva L.M., Alexandre L.A., Santos J.M. High-content analysis of breast cancer using single-cell deep transfer learning. J Biomol Screen 2016, 21:252-259.
54. Kraus O.Z., Frey B.J. Computer vision for high content screening. Crit Rev Biochem Mol Biol 2016, 51:102-109.
55. MacDonald M.L., Lamerdin J., Owens S., Keon B.H., Bilter G.K., Shang Z., et al. Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol 2006, 2:329-337.
56. Loo L.-H., Wu L.F., Altschuler S.J. Image-based multivariate profiling of drug responses from single cells. Nat Methods 2007, 4:445-453.
57. Young D.W., Bender A., Hoyt J., McWhinnie E., Chirn G.-W., Tao C.Y., et al. Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat Chem Biol 2008, 4:59-68.
58. Slack M.D., Martinez E.D., Wu L.F., Altschuler S.J. Characterizing heterogeneous cellular responses to perturbations. Proc Natl Acad Sci U S A 2008, 105:19306-19311.
59. Low J., Chakravartty A., Blosser W., Dowless M., Chalfant C., Bragger P., et al. Phenotypic fingerprinting of small molecule cell cycle kinase inhibitors for drug discovery. Curr Chem Genomics 2009, 3:13-21.
60. Gustafsdottir S.M., Ljosa V., Sokolnicki K.L., Anthony Wilson J., Walpita D., Kemp M.M., et al. Multiplex cytological profiling assay to measure diverse cellular states. PLOS ONE 2013, 8:e80999.
61. Pardo-Martin C., Allalou A., Medina J., Eimon P.M., Wählby C., Fatih Yanik M. High-throughput hyperdimensional vertebrate phenotyping. Nat Commun 2013, 4:1467.
62. Tanaka M., Bateman R., Rauh D., Vaisberg E., Ramachandani S., Zhang C., et al. An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol 2005, 3:e128.
63. Futamura Y., Kawatani M., Kazami S., Tanaka K., Muroi M., Shimizu T., et al. Morphobase, an encyclopedic cell morphology database, and its use for drug target identification. Chem Biol 2012, 19:1620-1630.
64. Woehrmann M.H., Bray W.M., Durbin J.K., Nisam S.C., Michael A.K., Glassey E., et al. Large-scale cytological profiling for functional analysis of bioactive compounds. Mol Biosyst 2013, 9:2604-2617.
65. Schulze C.J., Bray W.M., Woerhmann M.H., Stuart J., Lokey R.S., Linington R.G. Function-first lead discovery: mode of action profiling of natural product libraries using image-based screening. Chem Biol 2013, 20:285-295.
66. Ochoa J.L., Bray W.M., Lokey R.S., Linington R.G. Phenotype-guided natural products discovery using cytological profiling. J Nat Prod 2015, 78:2242-2248.
67. Kurita K.L., Glassey E., Linington R.G. Integration of high-content screening and untargeted metabolomics for comprehensive functional annotation of natural product libraries. Proc Natl Acad Sci U S A 2015, 10.1073/pnas.1507743112.
68. Reisen F., Sauty de Chalon A., Pfeifer M., Zhang X., Gabriel D., Selzer P. Linking phenotypes and modes of action through high-content screen fingerprints. Assay Drug Dev Technol 2015, 13:415-427.
69. Mayer T.U., Kapoor T.M., Haggarty S.J., King R.W., Schreiber S.L., Mitchison T.J. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 1999, 286:971-974.
70. Eggert U.S., Kiger A.A., Richter C., Perlman Z.E., Perrimon N., Mitchison T.J., et al. Parallel chemical genetic and genome-wide RNAi screens identify cytokinesis inhibitors and targets. PLoS Biol 2004, 2:e379.
71. Castoreno A.B., Smurnyy Y., Torres A.D., Vokes M.S., Jones T.R., Carpenter A.E., et al. Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis. Nat Chem Biol 2010, 6:457-463.
72. Breinig M., Klein F.A., Huber W., Boutros M. A chemical-genetic interaction map of small molecules using high-throughput imaging in cancer cells. Mol Syst Biol 2015, 11:846.
73. Kang J., Hsu C.-H., Wu Q., Liu S., Coster A.D., Posner B.A., et al. Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines. Nat Biotechnol 2016, 34:70-77.
74. Rihel J., Prober D.A., Arvanites A., Lam K., Zimmerman S., Jang S., et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010, 327:348-351.
75. Bray M.-A., Singh S., Han H., Davis C.T., Borgeson B., Hartland C., et al. Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes. Nature Protocols 2016, in press.
76. Carpenter A.E., Jones T.R., Lamprecht M.R., Clarke C., Kang I.H., Friman O., et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 2006, 7:R100.
77. Wawer M.J., Li K., Gustafsdottir S.M., Ljosa V., Bodycombe N.E., Marton M.A., et al. Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling. Proc Natl Acad Sci U S A 2014, 111:10911-10916.
78. Neumann B., Walter T., Hériché J.-K., Bulkescher J., Erfle H., Conrad C., et al. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature 2010, 464:721-727.
79. Collinet C., Stöter M., Bradshaw C.R., Samusik N., Rink J.C., Kenski D., et al. Systems survey of endocytosis by multiparametric image analysis. Nature 2010, 464:243-249.
80. Liberali P., Snijder B., Pelkmans L. A hierarchical map of regulatory genetic interactions in membrane trafficking. Cell 2014, 157:1473-1487.
81. Ohya Y., Sese J., Yukawa M., Sano F., Nakatani Y., Saito T.L., et al. High-dimensional and large-scale phenotyping of yeast mutants. Proc Natl Acad Sci U S A 2005, 102:19015-19020.
82. 2+-sensitive mutants of Saccharomyces cerevisiae. Eukaryot Cell 2007, 6:817-830.
83. Vizeacoumar F.J., van Dyk N., Vizeacoumar F.S., Cheung V., Li J., Sydorskyy Y., et al. Integrating high-throughput genetic interaction mapping and high-content screening to explore yeast spindle morphogenesis. J Cell Biol 2010, 188:69-81.
84. Horn T., Sandmann T., Fischer B., Axelsson E., Huber W., Boutros M. Mapping of signaling networks through synthetic genetic interaction analysis by RNAi. Nat Methods 2011, 8:341-346.
85. Laufer C., Fischer B., Billmann M., Huber W., Boutros M. Mapping genetic interactions in human cancer cells with RNAi and multiparametric phenotyping. Nat Methods 2013, 10:427-431.
86. Laufer C., Fischer B., Huber W., Boutros M. Measuring genetic interactions in human cells by RNAi and imaging. Nat Protoc 2014, 9:2341-2353.
87. Fischer B., Sandmann T., Horn T., Billmann M., Chaudhary V., Huber W., et al. A map of directional genetic interactions in a metazoan cell. eLife 2015, 4. 10.7554/eLife.05464.
88. Singh S., Wu X., Ljosa V., Bray M.-A., Piccioni F., Root D.E., et al. Morphological profiles of RNAi-induced gene knockdown are highly reproducible but dominated by seed effects. PLOS ONE 2015, 10:e0131370.
89. Lamb J., Crawford E.D., Peck D., Modell J.W., Blat I.C., Wrobel M.J., et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313:1929-1935.
90. Ohnuki S., Oka S., Nogami S., Ohya Y. High-content, image-based screening for drug targets in yeast. PLoS ONE 2010, 5:e10177.
91. Iwaki A., Ohnuki S., Suga Y., Izawa S., Ohya Y. Vanillin inhibits translation and induces messenger ribonucleoprotein (mRNP) granule formation in Saccharomyces cerevisiae: application and validation of high-content, image-based profiling. PLOS ONE 2013, 8:e61748.
92. Okada H., Ohnuki S., Roncero C., Konopka J.B., Ohya Y. Distinct roles of cell wall biogenesis in yeast morphogenesis as revealed by multivariate analysis of high-dimensional morphometric data. Mol Biol Cell 2014, 25:222-233.
93. Piotrowski J.S., Okada H., Lu F., Li S.C., Hinchman L., Ranjan A., et al. Plant-derived antifungal agent poacic acid targets β-1,3-glucan. Proc Natl Acad Sci 2015, 112:E1490-E1497.
94. Sundaramurthy V., Barsacchi R., Samusik N., Marsico G., Gilleron J., Kalaidzidis I., et al. Integration of chemical and RNAi multiparametric profiles identifies triggers of intracellular mycobacterial killing. Cell Host Microbe 2013, 13:129-142.
95. Sundaramurthy V., Barsacchi R., Chernykh M., Stöter M., Tomschke N., Bickle M., et al. Deducing the mechanism of action of compounds identified in phenotypic screens by integrating their multiparametric profiles with a reference genetic screen. Nat Protoc 2014, 9:474-490.
96. Swinney D.C. The contribution of mechanistic understanding to phenotypic screening for first-in-class medicines. J Biomol Screen 2013, 18:1186-1192.
97. Zheng W., Thorne N., McKew J.C. Phenotypic screens as a renewed approach for drug discovery. Drug Discov Today 2013, 18:1067-1073.
98. Lee J.A., Berg E.L. Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches. J Biomol Screen 2013, 18:1143-1155.
99. Solmesky L.J., Weil M. Personalized drug discovery: HCA approach optimized for rare diseases at Tel Aviv University. Comb Chem High Throughput Screen 2014, 17:253-255.
100. Ross N.T., Wilson C.J. In vitro clinical trials: the future of cell-based profiling. Front Pharmacol 2014, 5:121.
101. Gibson C.C., Zhu W., Davis C.T., Bowman-Kirigin J.A., Chan A.C., Ling J., et al. Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation 2015, 131:289-299.
102. Kasai Y., Cagan R. Drosophila as a tool for personalized medicine: a primer. Pers Med 2010, 7:621-632.
103. Pandey U.B., Nichols C.D. Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev 2011, 63:411-436.
104. Dar A.C., Das T.K., Shokat K.M., Cagan R.L. Chemical genetic discovery of targets and anti-targets for cancer polypharmacology. Nature 2012, 486:80-84.